CHRS
Coherus Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.42
+3.65%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-2.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 9, 2026 | O'Donnell-Tormey Jill · director | A-Award | 60,000 | $1.45 |
| Jun 9, 2026 | Satvat Ali J. · director | A-Award | 60,000 | $1.45 |
| Jun 9, 2026 | Wahlstrom Mats · director | A-Award | 30,000 | $0.00 |
| Jun 9, 2026 | Wahlstrom Mats · director | A-Award | 60,000 | $1.45 |
| Jun 9, 2026 | Newcomer Lee Nisley · director | A-Award | 30,000 | $0.00 |
| Jun 9, 2026 | O'Donnell-Tormey Jill · director | A-Award | 30,000 | $0.00 |
| Jun 9, 2026 | Ryan Michael Lee · director | A-Award | 30,000 | $0.00 |
| Jun 9, 2026 | Karachun Rita A · director | A-Award | 60,000 | $1.45 |
| Jun 9, 2026 | Newton Charles W. · director | A-Award | 60,000 | $1.45 |
| Jun 9, 2026 | Satvat Ali J. · director | A-Award | 30,000 | $0.00 |
| Jun 9, 2026 | Karachun Rita A · director | A-Award | 30,000 | $0.00 |
| Jun 9, 2026 | Newton Charles W. · director | A-Award | 30,000 | $0.00 |
| Jun 9, 2026 | Ryan Michael Lee · director | A-Award | 60,000 | $1.45 |
| Jun 9, 2026 | Newcomer Lee Nisley · director | A-Award | 60,000 | $1.45 |
| Jun 2, 2026 | McMichael Bryan J · officer: Chief Financial Officer | A-Award | 25,000 | $1.59 |
| Jun 2, 2026 | Lanfear Dennis M · director, officer: President & CEO | A-Award | 400,000 | $1.59 |
| Jun 2, 2026 | McMichael Bryan J · officer: Chief Financial Officer | A-Award | 100,000 | $1.59 |
| Jun 2, 2026 | Lanfear Dennis M · director, officer: President & CEO | A-Award | 500,000 | $1.59 |
| Jun 2, 2026 | Lanfear Dennis M · director, officer: President & CEO | A-Award | 450,000 | $1.59 |
| Jun 2, 2026 | McMichael Bryan J · officer: Chief Financial Officer | A-Award | 30,000 | $1.59 |
| Jun 2, 2026 | Lanfear Dennis M · director, officer: President & CEO | A-Award | 225,000 | $1.59 |
| Jun 2, 2026 | McMichael Bryan J · officer: Chief Financial Officer | A-Award | 15,000 | $1.59 |
| Jun 2, 2026 | Lanfear Dennis M · director, officer: President & CEO | A-Award | 200,000 | $1.59 |
| Jun 2, 2026 | Lanfear Dennis M · director, officer: President & CEO | A-Award | 402,500 | $1.59 |
| Jun 2, 2026 | Lanfear Dennis M · director, officer: President & CEO | A-Award | 125,000 | $1.59 |
| Jan 26, 2026 | McMichael Bryan J · officer: Chief Financial Officer | A-Award | 225,000 | $1.59 |
| Jan 26, 2026 | Lanfear Dennis M · director, officer: President & CEO | A-Award | 750,000 | $2.06 |
| Jan 26, 2026 | Lanfear Dennis M · director, officer: President & CEO | A-Award | 375,000 | $0.00 |
| Jan 26, 2026 | McMichael Bryan J · officer: Chief Financial Officer | A-Award | 112,500 | $0.00 |
| Jan 22, 2026 | Lanfear Dennis M · director, officer: President & CEO | F-InKind | 11,839 | $1.55 |
Institutional positioning
13F filings over the trailing two quarters
New 53Increased 111Reduced 82Sold out 20
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Timothy G. Youngquist 2020 Irrevocable Trust | Increased | 13,050,623 | Aug 7, 2026 |
| BlackRock, Inc. | Increased | 12,003,316 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 10,365,074 | May 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 5,949,490 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 5,452,762 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 3,685,567 | Aug 12, 2026 |
| SAMSARA BIOCAPITAL, LLC | New Position | 3,428,571 | May 15, 2026 |
| Samsara BioCapital, LLC | Unchanged | 3,428,571 | Aug 14, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 3,121,578 | May 15, 2026 |
| Kohlberg Kravis Roberts & Co. L.P. | Unchanged | 3,036,076 | Aug 14, 2026 |
| KOHLBERG KRAVIS ROBERTS & CO. L.P. | Unchanged | 3,036,076 | May 15, 2026 |
| STATE STREET CORP | Increased | 2,382,305 | Aug 7, 2026 |
| STATE STREET CORP | Increased | 2,325,859 | May 15, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 2,302,001 | May 15, 2026 |
| TWO SIGMA INVESTMENTS, LP | Reduced | 2,259,412 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 9, 2026